Open access · OA
via Europe PMC
Epigenetic Mechanisms in Neurodegenerative Diseases: From Genetic Regulation to Therapeutic Potential.
Lv X, Huang M, Long W, Li X, Hu Z, Feng Y, Du J, Long Q, Chen Y, Shi M, Qin D.
International journal of molecular sciences · 2026
Abstract
Neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), are multifactorial disorders in which genetic susceptibility alone cannot account for sporadic onset, clinical diversity, or age-dependent progression. Epigenetic mechanisms-DNA methylation, histone modifications, non-coding RNAs, and m6A RNA methylation-bridge environmental and intracellular cues to stable gene expression changes. Emerging evidence associates epigenetic dysregulation with amyloid-β/tau pathology in AD, α-synuclein pathology in PD, and TDP-43/C9orf72-associated toxicity in ALS, while functional studies suggest that selected epigenetic alterations may contribute to these processes. In this narrative review, we distinguish associative, functional, and mechanistic evidence using claim-specific criteria based on experimental perturbation, direct molecular assessment, and pathway-dependence or rescue testing, while considering the study system. We further evaluate the translational promise of epigenetic biomarkers in liquid biopsies, while emphasizing the major barriers that separate bench findings from bedside application, including poor target specificity, limited blood-brain barrier penetration, and the absence of biomarker-guided patient stratification. By integrating pathological mechanisms, biomarker development, and therapeutic strategies, this review argues that future epigenetic research in neurodegeneration must prioritize causal validation, CNS-penetrant drug development, and prospective trials integrating epigenetic profiling to achieve meaningful clinical impact.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3390/ijms27209322
- Canonical
- link ↗
- Fetched
- 2026-10-30 MST
Cite this
APA
X, L., M, H., W, L., X, L., Z, H., Y, F., J, D., Q, L., Y, C., M, S., & D., Q. (2026). Epigenetic Mechanisms in Neurodegenerative Diseases: From Genetic Regulation to Therapeutic Potential. <em>International journal of molecular sciences</em>. https://doi.org/10.3390/ijms27209322
Vancouver
X L, M H, W L, X L, Z H, Y F, et al. Epigenetic Mechanisms in Neurodegenerative Diseases: From Genetic Regulation to Therapeutic Potential. International journal of molecular sciences. 2026. doi:10.3390/ijms27209322.
BibTeX
@article{lv2026Epigen,
title = {Epigenetic Mechanisms in Neurodegenerative Diseases: From Genetic Regulation to Therapeutic Potential.},
author = {Lv X and Huang M and Long W and Li X and Hu Z and Feng Y and Du J and Long Q and Chen Y and Shi M and Qin D.},
journal = {International journal of molecular sciences},
year = {2026},
doi = {10.3390/ijms27209322},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cells 2026
Open access · OA
Immunosenescence and Inflammaging as Drivers of Neurodegeneration: Cellular Mechanisms, Neuroimmune Crosstalk, and Therapeutic Implications.
Frontiers in pharmacology 2025
Open access · OA
Epigenetic pharmacology in aging: from mechanisms to therapies for age-related disorders.
Experimental Gerontology 2024
Open access · CC-BY
Influence of human gut microbiome on the healthy and the neurodegenerative aging
Genes and Immunity 2021
Open access · OA
The aging gut microbiome and its impact on host immunity
Genes 2024
Open access · CC-BY
Epigenetic Mechanisms in Aging: Extrinsic Factors and Gut Microbiome
Microbiome research reports 2026
Open access · OA